SMS Pharmaceuticals receives EIR from USFDA for Central Laboratory Analytical Services
The inspection, conducted from June 23 to June 25, 2025, concluded with zero Form 483 observations
The inspection, conducted from June 23 to June 25, 2025, concluded with zero Form 483 observations
Delegates also visited Emami’s WHO-GMP-certified manufacturing plant and Zandu Foundation for Healthcare farms for hands-on exposure to quality practices,
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the U.S. to meet the needs of patients in the U.S.
This project shall be implemented through incorporation of a new joint venture company in Zambia
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
Subscribe To Our Newsletter & Stay Updated